ืคื™ืœื˜ืจื™ื

โ‚ช
ืœ
โ‚ช
6 ืžื•ืฆืจื™ื
ืžื™ื™ืŸ ืข"ื™
ืžื™ื™ืŸ ืข"ื™
ืื•ืคื•ืœื ื˜ ืกื˜ 5 ืžื•ืฆืจื™ื ื‘ืงื•ืคืกื ื–ื”ื‘-pharm2u
ืื•ืคื•ืœื ื˜ ืกื˜ 5 ืžื•ืฆืจื™ื ื‘ืชื™ืง ื‘ื“ ื–ื”ื‘-pharm2u
ื‘ืœื•ืžืคื™ืœื“ ืกื˜ 5 ืคืจื™ื˜ื™ื +ื›ื™ืกื•ื™ ืขื™ื ื™ื™ื ื‘ืงื•ืคืกื-pharm2u
ืกื˜ 3 ืžื•ืฆืจื™ื ืœื˜ื™ืคื•ื— ื”ื™ื“ื™ื™ื+ืชื™ืง-pharm2u
ืกื˜ 5 ืžื•ืฆืจื™ื ื‘ืงื•ืคืกื ืฉื—ื•ืจ ืœื‘ืŸ-pharm2u
ืกื˜ ื’ื•ืœื“ ืจื•ื– 5 ืžื•ืฆืจื™ื ืขื ืชื™ืง ืจื—ืฆื”-pharm2u

ืฉื™ืจื•ืช ืžืฉืœื•ื—ื™ื ืื™ื›ื•ืชื™ ื•ืžื”ื™ืจ

ืœื‘ื—ื™ืจืชื›ื: ืžืฉืœื•ื— ืขื ืฉืœื™ื— ืขื“ ื”ื‘ื™ืช ,ืžืฉืœื•ื— ืœื ืงื•ื“ืช ืื™ืกื•ืฃ ืื• ืื™ืกื•ืฃ ืขืฆืžื™. ืžืขืœ 399 ืฉ"ื—, ื”ืžืฉืœื•ื— ืœื ืง' ืื™ืกื•ืฃ ื—ื™ื ื